3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Lymphoma
16
Multiple Myeloma
13
Neoplasm Metastasis
10
Leukemia, Myeloid, Acute
10
Melanoma
9
Lung Neoplasms
9
Prostatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Lymphoma, Non-Hodgkin
6
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Neuroblastoma
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, Follicular
4
Burkitt Lymphoma
4
Wilms Tumor
3
Small Cell Lung Carcinoma
3
Sarcoma, Kaposi
3
Sarcoma
3
Rhabdoid Tumor
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Ovarian Neoplasms
3
Osteosarcoma
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Interventions
ponatinib
4
pembrolizumab
3
Rituximab
3
Gemcitabine
3
Cyclophosphamide
3
130-nm albumin-bound paclitaxel
3
pralsetinib
2
napabucasin
2
Vincristine
2
Prednisone
2
Irinotecan
2
Imatinib Mesylate
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
Brentuximab Vedotin
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
ricolinostat
1
pomalidomide
1
pamiparib
1
nirogacestat
1
nilotinib
1
ibritumomab tiuxetan
1
denileukin diftitox
1
bosutinib
1
blinatumomab
1
Vorinostat
1
Temozolomide
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Histologic Type
×
Biopsy
×
Clear all
No trials found.